Atlas Trials

A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Clinical trial NCT00629967 · COMPLETED

Trial details

NCT number
NCT00629967
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis CGenotype
Start date
2005-04-01
Primary completion
2007-05-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.